Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(254)
•••
Viking2233
X
View Profile
View Bullboard History
Post by
Viking2233
on Jul 28, 2024 5:33pm
Pete the Paid Pumper
You really need to take a breath and get a life Pete. I hope you are getting paid well to go through the news tab and copy and paste. We all know the news and we all thought the news would move the
...more
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 28, 2024 4:02pm
Health Canada Approved - Canadian Hospitals Joining In
3 Study Locations Cumming School of Medicine Unity Health Toronto University Health Network
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 28, 2024 3:56pm
Turkey Ministry of Health is recruiting to stop AKI
6 Study Locations Gazi University Istanbul University Kosuyolu High Specialization Training and Research Hospital Dialysis Hospital Kocaeli University Sutcu Imam University
(254)
•••
Viking2233
X
View Profile
View Bullboard History
Comment by
Viking2233
on Jul 28, 2024 11:31am
RE:The LSALT study currently has 9 locations
Hi Pete, Where are the 9 locations? I am only aware of 5 locations in Turkey currently dosing? We have 3 apparently coming in Canada with 1 location in Calgary and 2 locations in Toronto but
...more
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 28, 2024 11:23am
New Mechanism - Decreasing Biomarkers
"Collectively, a greater proportion of the biomarkers decreased from baseline at day 3 and EOT in the LSALT peptide treatment group compared with placebo (63.1% vs 54.8%, OR 1.41 95% CI 1.13 to 1
...more
(6)
•••
Renal22
X
View Profile
View Bullboard History
Comment by
Renal22
on Jul 28, 2024 11:16am
RE:Petite Pete on a Roll
RiverPetefolk
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 28, 2024 11:16am
The LSALT study currently has 9 locations
(254)
•••
Viking2233
X
View Profile
View Bullboard History
Post by
Viking2233
on Jul 27, 2024 7:31pm
Petite Pete on a Roll
Now that you have replayed everything Arch has accomplished, which is impressive to say the least. Pete, I have received a few private messages asking if you work for Arch. I have no idea if you do
...more
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 4:59pm
10 Best Canadian Biotech Stocks - Article
1) Bellus Health 2) Finnec Pharma 3) Sernova Corp 4) Arch Biopartners
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 3:32pm
Arch Biopartners 2025 TSX Venture 50
Time Will Tell
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 3:26pm
Arch Biopartners 2022 TSX Venture 50
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 3:25pm
Arch Biopartners 2019 TSX Venture 50
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 2:22pm
Chronic Disease - Yes Please
Since July 2021 the Canaidan Institutes of Health Research granted Arch Scientists $750,000 and $1,109,250 to study the role of dipeptidase-1(DPEP-1) in renal inflammation and chronic kidney
...more
(69)
•••
PeptidePete
X
View Profile
View Bullboard History
Post by
PeptidePete
on Jul 27, 2024 2:15pm
Antibody Anybody
In June 2021 Arch filed a new Patent application for novel Antibody candidates targeting DPEP-1 mediated Organ inflammation. "This new class of antibodies that we are developing at Arch
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >